Expanding the clinical trial portfolio for lung cancer
Anti-HER2 strategies in breast cancer: the ALTTO trial
An MRI-based approach to prostate cancer diagnosis: a urologist’s stance in the debate
Will diffusion-weighted MRI replace PET-CT in lung cancer?
Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer